EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2025

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Net Income for Earnings Per Share Calculations:
Income from continuing operations, net of tax	$	292.3	$	362.1	$	991.8	$	1,051.0
Net loss attributable to noncontrolling interests	(0.8)		(1.4)		(4.1)		(3.6)
Income from continuing operations attributable to Edwards Lifesciences Corporation	293.1		363.5		995.9		1,054.6
(Loss) income from discontinued operations	(2.0)		2,707.3		(13.6)		2,734.4
Net income attributable to Edwards Lifesciences Corporation	$	291.1	$	3,070.8	$	982.3	$	3,789.0
Weighted Average Shares:
Basic weighted-average shares outstanding	584.7		597.2		586.2		600.3
Dilutive effect of stock plans	1.0		0.9		1.0		1.9
Dilutive weighted-average shares outstanding	585.7		598.1		587.2		602.2
Earnings per Share:
Basic:
Continuing operations	$	0.50	$	0.61	$	1.70	$	1.76
Discontinued operations	—		4.53		(0.02)		4.55
Basic earnings per share	$	0.50	$	5.14	$	1.68	$	6.31
Diluted:
Continuing operations	$	0.50	$	0.61	$	1.70	$	1.75
Discontinued operations	—		4.52		(0.03)		4.54
Diluted earnings per share	$	0.50	$	5.13	$	1.67	$	6.29